Clinical trial
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine in Cameroon
NCT03719066 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine in Cameroon
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 23, 2018
- Completion date
- October 5, 2021
- Enrollment
- 181 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse reaction to cholera vaccine, cholera vaccination reaction